The Natural History of Secondary Progressive Multiple Sclerosis: Observations from the London Study Group
Overview
Authors
Affiliations
Rituximab in secondary progressive multiple sclerosis: a meta-analysis.
Intarakhao P, Laipasu T, Jitprapaikulsan J, Apiraksattayakul N, Kosiyakul P, Siritho S Ann Clin Transl Neurol. 2024; 11(10):2707-2718.
PMID: 39186371 PMC: 11514939. DOI: 10.1002/acn3.52186.
Leussink V, Jankovic M, Groth M, Schuh K, Schwab Sauerbeck I, Hoffmann O Brain Behav. 2024; 14(6):e3548.
PMID: 38841819 PMC: 11154816. DOI: 10.1002/brb3.3548.
Ziemssen T, Bhan V, Chataway J, Chitnis T, Cree B, Kubala Havrdova E Neurol Neuroimmunol Neuroinflamm. 2022; 10(1).
PMID: 36414428 PMC: 9682625. DOI: 10.1212/NXI.0000000000200064.
Ribbons K, McElduff P, Boz C, Trojano M, Izquierdo G, Duquette P PLoS One. 2015; 10(6):e0122686.
PMID: 26046348 PMC: 4457630. DOI: 10.1371/journal.pone.0122686.
Higginson I, Vivat B, Silber E, Saleem T, Burman R, Hart S BMC Palliat Care. 2006; 5:7.
PMID: 17014714 PMC: 1615868. DOI: 10.1186/1472-684X-5-7.